Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancerAnna E. Harris, Jennie Jeyapalan, Emad A. Rakha et al.|Frontiers in Endocrinology|2022Cited by 46
Evolving DNA repair synthetic lethality targets in cancerSanat Kulkarni, Srinivasan Madhusudan, Juliette Brownlie et al.|Bioscience Reports|2022Cited by 25
Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancersAdel Alblihy, Srinivasan Madhusudan, Reem Ali et al.|npj Precision Oncology|2022Cited by 23
Targeting DNA damage repair precision medicine strategies in cancerJuliette Brownlie, Srinivasan Madhusudan, Sanat Kulkarni et al.|Current Opinion in Pharmacology|2023Cited by 19
Towards Personalized Management of Ovarian CancerMashael Algethami, Srinivasan Madhusudan, Sanat Kulkarni et al.|Cancer Management and Research|2022Cited by 18